Sanofi Consumer Healthcare India Ltd. (SANOFICONR): Sanofi Consumer Healthcare India 52 Week Low Streak: Second Straight Session Near Yearly Low
- September 17, 2026
- Posted by: Harsh Piplani
- Category: News
Sanofi Consumer Healthcare India 52 Week Low Streak has now held for its second straight session, with the stock trading within 2% of its 52-week low again. Across the streak, the cumulative change is -2.41%, while the latest trough stands at Rs 3,969 against the current price of Rs 3,969. The supplied data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued decline.
The previous close was Rs 4,007.6, the stock opened at Rs 3,992 and touched an intraday high of Rs 4,038.05 before finishing at the day’s low. Turnover stood at Rs 0.1 crore, and market capitalisation was Rs 9,229.75 crore. For readers tracking Sanofi Consumer Healthcare India Share Price moves, the repeated-low pattern is more informative than a single session because it shows that the stock has remained pinned close to its yearly low over multiple trading days rather than only briefly slipping there once.
Sanofi Consumer Healthcare India 52 Week Low Streak: Consecutive Low Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,969 |
| Previous Close | Rs 4,007.6 |
| Today's Move | Rs -38.6 (-0.96%) |
| Open | Rs 3,992 |
| High | Rs 4,038.05 |
| Low | Rs 3,969 |
| Turnover | Rs 0.1 crore |
| Market Capitalisation | Rs 9,229.75 crore |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) traded at Rs 3,969 versus the previous close of Rs 4,007.6, a fall of 0.96%. The stock opened at Rs 3,992, reached a high of Rs 4,038.05, touched a low of Rs 3,969.
Sanofi Consumer Healthcare India Share Price Today closed at Rs 3,969, down Rs 38.6 or 0.96% from the previous close of Rs 4,007.6. The day began at Rs 3,992, moved as high as Rs 4,038.05, and then finished at the day’s low, which shows that the close sat at the weakest point in the session. That close near the session floor keeps the stock inside its broader downtrend and reinforces the relevance of the Sanofi Consumer Healthcare India 52 Week Low Streak.
Turnover of Rs 0.1 crore suggests the day was not marked by a large traded value, so the price reading should be taken as a factual market update rather than a comment on participation. The market capitalisation of Rs 9,229.75 crore places the company in a meaningful listed-company bracket, but size alone does not explain the repeated yearly low pattern. In the context of Sanofi Consumer Healthcare India Stock News, the key point is that the stock has stayed close to its 52-week trough for a second straight session, which is very different from a one-off dip that quickly recovers.
What the Repeated 52-Week Lows Show
Sanofi Consumer Healthcare India 52 Week Low Streak now points to a pattern of persistence rather than a single-day slide. The stock has traded within 2% of its one-year low for the second straight session, and the cumulative move across that stretch is -2.41%. That matters because it shows the decline has not been confined to one session; the stock has remained close to the lower boundary of its annual range across back-to-back sessions.
The latest 52-week low is the reference level that the market continues to test, and the supplied data confirms that the current price remains right at that area. The stock has not necessarily set a fresh 52-week low today, but it has stayed near that floor long enough to form a visible streak. For readers following Sanofi Consumer Healthcare India Back To Back 52 Week Lows, the important distinction is that the data confirms the pattern, not a reason behind it. No company-specific trigger can be inferred from the numbers alone.
This is also why the phrase Sanofi Consumer Healthcare India New One Year Low should be read carefully. The event definition here is proximity to the low, not a claim that the level was broken each day. The trend is notable because it has been repeated, not because it is automatically decisive on its own.
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 9,229.75 crore |
| P/E Ratio | 34.7x |
| P/B Ratio | 26.53x |
| ROE | 73.2% |
| ROCE | 98.11% |
| EPS | Rs 115.5 |
| Book Value Per Share | Rs 151.07 |
| Dividend Yield | 1.87% |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) fundamental metrics show P/E 34.7x, P/B 26.53x, ROE 73.2%, ROCE 98.11%. These figures provide context only and are not a buy or sell signal.
Sanofi Consumer Healthcare India Ltd. has a market capitalisation of Rs 9229.75 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 34.7x, P/B at 26.53x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 73.2% and ROCE of 98.11%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 115.5, book value per share of Rs 151.07, dividend yield of 1.87%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 28.1x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 34.7x |
| Benchmark Median P/E | 28.1x |
| Benchmark Average P/E | 40.43x |
| Benchmark P/E Range | 0x to 661.74x |
| Company P/B Ratio | 26.53x |
| Benchmark Median P/B | 2.92x |
| Company ROE | 73.2% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 98.11% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 9,229.75 crore |
| Benchmark Median Market Cap | Rs 730.86 crore |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a P/E ratio of 34.7x, which is above the benchmark median of 28.1x, a difference of +23.49%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a ROE of 73.2%, which is above the benchmark median of 11.7%, a difference of +525.64%. Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a ROCE of 98.11%, which is above the benchmark median of 13.61%, a difference of +620.87%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Procter & Gamble Health Ltd. | PGHL | 9,062.68 | 25.39 | 14.72 | 62.18 | 84.86 |
| Suven Life Sciences Ltd. | SUVEN | 9,431.94 | 0 | 17.08 | -101.8 | -78.71 |
| Blue Jet Healthcare Ltd. | BLUEJET | 10,425.31 | 45.45 | 4.77 | 19.88 | 27.18 |
| Strides Pharma Science Ltd. | STAR | 10,622.91 | 17.86 | 3.35 | 20.31 | 18.57 |
| Sequent Scientific Ltd. | VIYASH | 10,887.46 | 61.47 | 3.74 | 9.06 | 13.1 |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a P/E ratio of 34.7x compared with the displayed peer median of 25.39x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 73.2% compares with a peer median of 19.88% across the companies shown in the table. ROCE stood at 98.11% versus the displayed peer median of 18.57%, providing a capital-efficiency comparison. Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a market capitalisation of Rs 9,229.75 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching
- The stock has now traded within 2% of its 52-week low for a second straight session, which keeps the Sanofi Consumer Healthcare India 52 Week Low Streak in focus.
- The cumulative move across the streak is -2.41%, showing that the weakness has persisted across more than one trading day.
- The latest price of Rs 3,969 remains close to the one-year floor, so Sanofi Consumer Healthcare India Share Price Today is still tied to the lower end of its range.
- The company’s valuation stays elevated versus the supplied industry median, which makes the repeated low pattern more notable in a Sanofi Consumer Healthcare India Stock Analysis context.
- The current data confirms the price pattern, but it does not confirm a company-specific cause, which is important for Sanofi Consumer Healthcare India Stock News readers.
About the Company
Sanofi Consumer Healthcare India Ltd. is listed on the Indian market under the symbol SANOFICONR and operates in the Healthcare sector within Pharmaceuticals & Drugs. The company’s current market capitalisation is Rs 9,229.75 crore, and its reported metrics show strong profitability ratios alongside a premium valuation.
For investors following Sanofi Consumer Healthcare India Share Price Update, the company stands out because the market price has stayed near a 52-week low streak even though return ratios such as ROE and ROCE are high in the supplied dataset. That combination makes the stock worth monitoring as a price-pattern story within the broader healthcare universe.
Track Sanofi Consumer Healthcare India on Univest
Keep tracking Sanofi Consumer Healthcare India 52 Week Low Streak on Univest for the latest share price update, stock news and market context. The article will continue to focus on the repeated near-low pattern, valuation snapshot and peer comparison as fresh data comes in.
Frequently Asked Questions
What does Sanofi Consumer Healthcare India 52 Week Low Streak mean?
Ans. It means the stock has traded within 2% of its 52-week low for consecutive sessions. In this case, the streak is the second straight session, based on the supplied data.
Did Sanofi Consumer Healthcare India set a new 52-week low today?
Ans. The data confirms the stock traded near its 52-week low again, but it does not say the level was necessarily broken today. The event is about proximity to the low, not a guaranteed fresh low.
Why is the repeated low pattern important for Sanofi Consumer Healthcare India Share Price Today?
Ans. Because it shows the stock has remained close to its yearly trough for more than one session. That repeated pattern is more informative than a one-day move when assessing the current price action.
Is Sanofi Consumer Healthcare India cheap on valuation?
Ans. Not by the supplied multiples. The stock trades at P/E 34.7 and P/B 26.53, both above the industry medians given in the sector snapshot. The company trades at a P/E ratio of 34.7x.
How does Sanofi Consumer Healthcare India compare with peers?
Ans. It trades at a higher P/B than the supplied peer set and a P/E that is above some peers and below others. The stock looks expensive versus several listed comparables in the same industry bucket.
What should investors monitor next in Sanofi Consumer Healthcare India Stock News?
Ans. Track whether the stock stays pinned near the same low zone, whether the valuation gap versus peers changes, and whether any new company or sector update alters the current price pattern.
Track Sanofi Consumer Healthcare India Ltd. (SANOFICONR) Share Price on Univest
Use Sanofi Consumer Healthcare India Ltd. (SANOFICONR) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
